Delivery Order SPE2DB25D3306-SPE2DB25FUBMH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,132.81 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count units) on August 6, 2025, with completion expected by August 7, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contractor will perform this order from its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Mesalamine DR 1.2 GM tablets in quantities of 60 units. This is a firm fixed-price delivery order with a ceiling value of $1,556.04, with an ultimate completion date of September 4, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mesalamine DR 1.2 GM tablets (120 count) on August 29, 2025, with a ceiling value of $1,419.34 and completion deadline of September 2, 2025. This firm fixed-price delivery order was awarded without set-aside restrictions through open competition. The order will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $19,317.32 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of June 20, 2025, with performance occurring at the vendor's location in Conshohocken, Pennsylvania. Mesalamine is an anti-inflammatory medication commonly used to treat inflammatory bowel diseases such as ulcerative colitis and Crohn's...
- The Defense Logistics Agency awarded a delivery order valued at $1,083.24 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count). This is a firm fixed-price delivery order with a completion date of September 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $5,414.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count) with a ceiling value of $1,512.73. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count) at a contract ceiling value of $1,836.05. This firm fixed price delivery order, which is not set-aside designated, is scheduled for ultimate completion on May 7, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count units) under a firm fixed-price contract valued at $1,076.10. This non-set-aside award is part of a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle running through December 2026 that serves as the primary global pharmaceutical support mechanism for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mesalamine DR 1.2 GM tablets (120 count) with a ceiling value of $1,924.72 under a firm fixed-price contract structure. This competitively awarded, non-set-aside delivery order was executed on April 30, 2025, with an ultimate completion date of May 1, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUBMHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count units) with a ceiling value of $3,721.27. This is a firm fixed-price delivery order with an ultimate completion date of April 24, 2025, with performance to be completed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet federal procurement requirements through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999 prime vendor agreement running through December 2026 that supports global pharmaceutical supply to military healthcare programs. AmerisourceBergen is a major pharmaceutical distributor serving federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Mesalamine is a gastrointestinal anti-inflammatory medication commonly used in military and veteran healthcare settings for inflammatory bowel disease treatment.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 4/23/25 |